Organization
Neurocrine Biosciences Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Neurocrine Biosciences Inc.
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced an update on its business performance, including preliminary ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 36th Annual J.P. Morgan Healthcare Conference ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the BMO Capital Markets 2017 Prescriptions for ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the BMO Capital Markets 2017 Prescriptions for ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new long-term data from the KINECT 4 ...
... with timely information, WallStEquities.com has issued free tailored Stock Review on IRWD, NBIX, COLL, and MYL which is a click away athttp://www.wallstequities.com/registration. The Generic Drugs ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that new long-term data from the open-label KINECT ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 29th Annual Piper Jaffray Healthcare Conference ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the full manuscript of the long-term safety ...
... of which occurred in 2015. The exclusive licensing agreement in 2015 between Neurocrine Biosciences and Mitsubishi Tanabe Pharma to develop and commercialize Neurocrine Biosciences' VMAT2 ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended September ...
... Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that data for INGREZZA® (valbenazine) capsules, the first ...
... players which have been significantly contributing to the Women's health market are Neurocrine Biosciences, Gedeon Richter Plc, Ferring Pharmaceuticals, enteris BIOPHARMA, Bayer Healthcare, F. Hoffmann-La ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, CEO of Neurocrine Biosciences, ...
... Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended September ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, CEO of Neurocrine Biosciences, ...
... SAN DIEGO - Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it has initiated a Phase IIb clinical ...
Want to see the full history on Neurocrine Biosciences Inc.? Upgrade to RelSci Pro now!
Start My Free Trial